Health Sciences In The Media

New research from the University of Arizona Health Sciences found that people who suffer from migraine may benefit from green light therapy, which was shown to reduce the frequency and intensity of headaches and improve patient quality of life.

Many individuals recovering from COVID-19 are experiencing lingering symptoms that can last for weeks. One post-viral symptom is something called "brain fog." Dr. Shad Marvasti, an associate professor and director of public health and prevention curriculum at the University of Arizona College of Medicine in Phoenix, explains the symptoms of brain fog.

Dr. Victoria Maizes, executive director of the Andrew Weil Center for Integrative Medicine at the University of Arizona, discusses the “prescribing cascade” and the health risks to older adults who take multiple medications to treat different chronic conditions.

Report on the number of COVID cases among students at Arizona’s three state universities. Dr. Shad Marvasti from the University of Arizona College of Medicine says the amount of partying among students is a concern.

Many individuals recovering from COVID-19 are experiencing lingering symptoms that can last for weeks. One post-viral symptom is something called "brain fog." Dr. Shad Marvasti, an associate professor and director of public health and prevention curriculum at the University of Arizona College of Medicine in Phoenix, explains the symptoms of brain fog.

The 2020 University of Arizona Arthritis Center “Bear Down for Health: Sport and Science in the Era of COVID-19” livestream panel discussion and reception is Sept. 16 at 11 a.m.

Many health experts say the health risk of casting an in-person ballot is relatively low. In a risk-assessment chart co-created by Saskia Popescu, an epidemiologist at the University of Arizona, voting would go in the same low-medium risk category as playing golf or tennis.

John Galgiani, head of the University of Arizona’s Valley Fever Center for Excellence, is heading up vaccine research at the center and believes the vaccine shown to prevent valley fever in mice should be available for dogs, which also get infected in large numbers.

Efforts are underway to bring to market a vaccine for a fungal infection that occurs in the deserts of the Southwest. Dr. John Galgiani, director of the University of Arizona's Valley Fever Center for Excellence, is heading up vaccine research there and believes the vaccine shown to prevent valley fever in mice should be available for dogs, which also get infected in large numbers, as soon as next year.

Historically, older adults have been underrepresented in clinical trials for certain treatments. But with the coronavirus, experts say it is critical that older adults be included in vaccine trials since the virus can impact them at higher rates. Dr. Shad Marvasti, an associate professor at the University of Arizona College of Medicine – Phoenix, said medical research has been mostly limited to a certain demographic – specifically, "middle aged white men."